Master Drug Trial Phases with Picmonic for Medicine

With Picmonic, facts become pictures. We've taken what the science shows - image mnemonics work - but we've boosted the effectiveness by building and associating memorable characters, interesting audio stories, and built-in quizzing.

Drug Trial Phases

Drug Trial-athlon Phases
LauraY
There are five sequential phases in a drug trial, each with a different purpose and population size. The phases start from small scale Phase 0 trials which discern pharmacological properties in healthy volunteers, followed by Phase I studies were safety and response in patients with the disease of interest is evaluated. In Phase II, efficacy and side effect identification is completed, leading to Phase III trials where the new drug is compared with standard of care or placebo through randomized control trials. Finally, Phase IV trials represent post-marketing studies conducted after a drug is approved for use by the FDA for surveillance and evaluation of pharmacoeconomics.
14 KEY FACTS
PHASE 0
Phase 0
Phase (0)

Phase 0 is useful to eliminate drugs that don't measure up to even the most rudimentary requirements, saving time and money. Likewise it smooths the approval process to move on to the next drug trial phases in order to register a new compound.

Pharmacological Properties
Pharmacological Property Registration

The objective of Phase 0 trials is to show whether a drug's pharmacokinetics and pharmacodynamics warrant continued exploration. However, it will not demonstrate any therapeutic effect nor will it replace the dose escalation, safety, and tolerance studies required in Phase I.

Healthy Volunteers
Healthy Volunteer

In Phase 0 the drug is only given to a very small group of healthy volunteers, usually less than 15 individuals, who are administered a microdose, less than 1% of the therapeutic dose of the drug in question, for no more than seven days.

PHASE I
Phase I
Phase (1) Wand

In Phase I trials, researchers test an experimental drug or treatment in a small group of people, around 20 to 100 people, for the first time. Around 70% of drugs move to the next phase.

Safety
Ensure Safety Net

The objective is to evaluate the drug's safety, determine a safe dosage range, and identify side effects.

Patients with Disease of Interest
Diseased-guy

Phase I studies are usually conducted in patients with the disease of interest. The goal here is to determine what the drug's most frequent side effects are and, often, how the drug is metabolized and excreted. The number of subjects typically ranges from 20 to 80.

PHASE II
Phase II
Phase (2) Tutu

Phase II studies begin if Phase I studies don't reveal unacceptable toxicity. While the emphasis in Phase I is on safety, the emphasis in Phase II is on effectiveness. Phase II usually lasts months to 2 years, and 33% of drugs move to the next phase.

Efficacy and Side Effects
Efficacy-elephant vs Cider-effects

Phase II aims to obtain preliminary data on whether the drug works in people who have a certain disease or condition. For controlled trials, patients receiving the drug are compared with similar patients receiving a different treatment, usually an inactive substance (placebo), or a different drug. Safety continues to be evaluated, and short-term side effects are studied. Typically, the number of subjects in Phase II studies ranges from a few dozen to about 300.

PHASE III
Phase III
Phase (3) Tree

Phase III studies begin if evidence of effectiveness is shown in Phase II. These studies gather more information about safety and effectiveness, studying different populations and different dosages and using the drug in combination with other drugs. The number of subjects usually ranges from several hundred to about 3,000 volunteers. Phase II usually lasts 1 to 4 years. Only 25-30% of the drugs move to phase IV.

Comparison with Standard of Care or Placebo
Standard Care-bear and Sugar-pill

The purpose of Phase III is to evaluate how the new medication works in comparison to existing medications for the same condition.

Randomized Control Trial
Randomized Controller

Comparisons are achieved through double-blind randomization of volunteers into two groups where they receive the novel drug vs the comparison existing medication. Double-blind methodology helps to eliminate bias when interpreting results.

PHASE IV
Phase IV
Phase (4) Fork

Phase IV trials are post-marketing studies conducted after a drug is approved for use by the FDA. They are usually large studies, including several thousand volunteers with the disease/condition.

Surveillance
Surveillance-camera

The goal of Phase IV trials is to provide additional information including the treatment or drugs risks, benefits, and best use.

Pharmacoeconomics
Pharmaceuticals + Money Bag Prize

These post-marketing requirement and commitment studies are sponsored and conducted after the FDA has approved a product for marketing. The FDA uses these studies to gather additional information about a product's safety, efficacy, or optimal use.

Unlock all 14 facts & definitions with Picmonic Free!

Take the Drug Trial Phases Quiz

Picmonic's rapid review multiple-choice quiz allows you to assess your knowledge.

It's worth every penny

Our Story Mnemonics Increase Mastery and Retention

Memorize facts with phonetic mnemonics

Unforgettable characters with concise but impactful videos (2-4 min each)

Ace Your Medicine (MD/DO) Classes & Exams with Picmonic:

Over 1,180,000 students use Picmonic’s picture mnemonics to improve knowledge, retention, and exam performance.

Choose the #1 Medicine (MD/DO) student study app.

Picmonic for Medicine (MD/DO) covers information that is relevant to your entire Medicine (MD/DO) education. Whether you’re studying for your classes or getting ready to conquer the USMLE Step 1, USMLE Step 2 CK, COMLEX Level 1, or COMLEX Level 2, we’re here to help.

Works better than traditional Medicine (MD/DO) flashcards.

Research shows that students who use Picmonic see a 331% improvement in memory retention and a 50% improvement in test scores.